Latanoprost/Timolol Blumont

Timolol Maleate, the active ingredient in Latanoprost/Timolol Blumont, is a beta‑blocker presented as an ophthalmic solution for ocular use. It, together with Latanoprost, treats open‑angle glaucoma and ocular hypertension in adults.\n\nGNH India supplies Latanoprost/Timolol Blumont as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol Blumont is used in the management of ocular conditions that require reduction of intraocular pressure.\n\nOpen‑angle glaucoma: lowers intraocular pressure to slow disease progression.\nOcular hypertension: reduces pressure to prevent conversion to glaucoma.\nSecondary open‑angle glaucoma: assists in pressure control when other therapies are insufficient.

Common Side Effects:\n- Eye irritation or burning sensation\n- Blurred vision shortly after instillation\n- Redness of the conjunctiva\n- Increased eyelash growth\n- Darkening of the iris color\n\nSerious or Rare Side Effects:\n- Severe allergic reaction (e.g., angio‑edema)\n- Uveitis or iritis\n- Corneal edema or keratitis\n- Systemic beta‑blocker effects such as bradycardia, hypotension, or bronchospasm.

Latanoprost/Timolol Blumont should be used with caution in patients with certain conditions.\n\nPregnancy: safety not established; avoid unless benefit outweighs risk.\nBreastfeeding: unknown; consider discontinuation.\nRespiratory disease: may exacerbate asthma or COPD.\nCardiovascular disease: monitor heart rate and blood pressure.\nContact lens wearers: remove lenses before instillation and wait 15 minutes before reinserting.\nStore at room temperature: keep in the original container, protect from light and moisture.

Latanoprost/Timolol Blumont may interact with other medicines.\n\nMajor Interactions (Avoid):\n- Non‑selective beta‑blockers (e.g., propranolol): additive systemic beta‑blockade.\n- Other prostaglandin analogs: increased risk of ocular hyperpigmentation and irritation.\n- Sympathomimetic agents (e.g., epinephrine eye drops): may diminish intraocular‑pressure‑lowering effect.\n\nModerate Interactions (Monitor Closely):\n- Calcium‑channel blockers: possible alteration of ocular blood flow.\n- Systemic antihypertensives: monitor for excessive blood‑pressure reduction.\n- Topical ocular anesthetics: may increase corneal toxicity when used together.